Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease). by Mobina Faqani (22783963)

“…<p>Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease).…”

The significant decrease in GLT-1 levels observed in the nucleus accumbens of rats that had consumed morphine for fifty-six days was completely reversed by the co-administration of... by María Elena Quintanilla (8068691)

Mean Autism Spectrum Quotient (AQ) and Multidimensional Social Competence Scale (MSCS) total scores for Duke-Vanderbilt Misophonia Screening Questionnaire (DVMSQ) classifications o... by Silas Manning (22693338)

Subjects:

Characteristics of PLHIV in Jamaica who initiated ARV treatment between 2017–2019 with pre and post ART viral load tests (N = 4560). by Anya Cushnie (11269155)

Subjects:

Pairwise comparisons of the intervention effects by time point for physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for recovery parameter. by Vanessa Wellauer (18408477)

Subjects:

Rank order correlation of VADER words by TF-IDF. by Krishna Bathina (12883820)

Subjects:

Permutation test of the random forest model in the post-intervention data. by Kang Wu (160544)

Subjects:

Comparison of neutrophils, lymphocyte and platelet between the two groups. by Changxu Wang (17826805)

Subjects:

S1 File - by Changxu Wang (17826805)

Subjects:

Baseline patient characteristics and surgical and anesthetic datas. by Changxu Wang (17826805)

Subjects:

Postoperative pain assessment indexes, nausea and vomiting frequency, and postoperative recovery of patients in two groups. by Changxu Wang (17826805)

Subjects:

The flow chart of the study. by Changxu Wang (17826805)

Subjects:

Comparison of postoperative NLR, PLR, and SII between the two groups. by Changxu Wang (17826805)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects:

PRISMA flow chart. by Filip Stanicic (17808254)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects: